Improving Effectiveness of the Tuberculosis Prevention and Control Programs in Resource Limited Countries | Apply Online

Opportunity Summary:

This funding opportunity, titled "Improving Effectiveness of the Tuberculosis Prevention and Control Programs in Resource Limited Countries," is a continuation award issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It appears under Funding Opportunity Number CDC RFA PS14 141103CONT16 and is listed in the health funding activity category under CFDA 93.116. The central purpose of the opportunity is to strengthen and improve the performance and impact of tuberculosis (TB) prevention and control programs in countries where resources are limited, with the overall intent of reducing TB illness and death through better program implementation, management, and public health practice.

The mechanism for support is a cooperative agreement, which typically means the CDC expects to have substantial involvement in the funded work beyond simply providing funds. In practical terms, this usually involves ongoing collaboration, technical guidance, and joint planning between the recipient and CDC staff, especially in areas like program strategy, monitoring and evaluation approaches, and alignment with evidence-based TB control practices. Because the opportunity is labeled as a continuation, it is generally designed to extend or maintain an existing effort rather than launch a completely new project. Continuation opportunities often build on prior work, using lessons learned and existing partnerships to improve outcomes and scale effective approaches.

While the posting does not provide detailed programmatic requirements in the excerpt provided, the title and framing indicate a focus on improving effectiveness, which in TB programming commonly includes strengthening case detection and diagnosis, ensuring timely and effective treatment, improving treatment adherence and completion, enhancing contact investigation and preventive therapy where appropriate, bolstering laboratory and surveillance systems, and improving program management and quality improvement processes. In resource-limited settings, effectiveness improvements frequently also involve optimizing use of limited funds, building workforce capacity, integrating TB services with related programs (such as HIV services where relevant), and improving data systems so that decisions are guided by accurate, timely information.

Eligibility is listed broadly as "Others," with clarification noted as being located in an "Additional Information on Eligibility" text field that is not included in the excerpt. That wording typically signals that eligibility may be restricted to specific organizations, institutions, partners, or current recipients, which is common for continuation funding. The opportunity was created and posted on April 29, 2016, and the closing date for applications is June 30, 2016 (with both the original and current closing date shown as the same). The award ceiling is listed as 0, which usually indicates that a specific maximum award amount is not provided in this summary listing, may vary by recipient, or is defined elsewhere in the full announcement. The number of expected awards is not specified in the excerpt, which similarly suggests that the details may be available only in the full funding announcement or are contingent on continuation eligibility and the availability of funds.

In short, this CDC continuation cooperative agreement supports ongoing work to make TB prevention and control programs more effective in resource-limited countries, with CDC playing an active collaborative role. The listing highlights the administrative identifiers (CDC RFA PS14 141103CONT16, CFDA 93.116), the mechanism (cooperative agreement), the timeline (posted April 29, 2016; closed June 30, 2016), and the broad public health purpose (improving TB program effectiveness), while leaving key specifics such as exact eligibility limitations, project expectations, and funding levels to the full announcement text referenced by the grant listing.

Browse more business programs for Tuberculosis Research

Browse more opportunities from the same agency: HHS-CDC

Browse more opportunities from the same category: Health

Next opportunity: Capital Project

Previous opportunity: Directors Fellows Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA PS14 141103CONT16

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA PS14 141103CONT16) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS14 141103CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.